CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.710
-0.110 (-2.88%)
Apr 28, 2026, 4:00 PM EDT - Market closed

CervoMed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
34731943--
Market Cap Growth
-53.40%278.47%-55.39%---
Enterprise Value
1346-2733--
Last Close Price
3.717.902.347.63--
PS Ratio
8.5718.241.986.06--
PB Ratio
1.884.010.495.87--
P/TBV Ratio
1.884.010.495.87--
EV/Sales Ratio
3.3711.43-4.60--
Debt / Equity Ratio
-----1.38-2.74
Net Debt / Equity Ratio
-1.14-1.14-0.99-1.06-0.92-0.92
Asset Turnover
0.120.120.371.01--
Quick Ratio
4.574.5710.613.360.311.48
Current Ratio
4.914.9111.113.840.321.50
Return on Equity (ROE)
-93.92%-93.92%-69.95%---
Return on Assets (ROA)
-53.62%-53.62%-42.95%-69.12%-39.59%-
Return on Capital Employed (ROCE)
-155.30%-155.30%-46.50%-105.90%38.60%-223.00%
Earnings Yield
-78.51%-36.89%-84.35%-5.02%--
Buyback Yield / Dilution
-12.00%-12.00%-203.34%-413.65%88.49%-
Source: S&P Capital IQ. Standard template. Financial Sources.